Stacy Hurt shared a post on X/Twitter:
”Please join us at DIA2024 where I’ll be speaking at the opening plenary about patient involvement in drug development, as well as 2 other panels about site accessibility and patient guided clinical research. Still time to register: DIA – DIA 2024.”
Source: Stacy Hurt/X
Stacy Hurt is a Global Annual Meeting Program Committee member for Drug Information Association (DIA) and co-chair of the board for the American Cancer Society Northeast Region (Pittsburgh market). Stacy’s impact earned her a spot on Fierce Pharma’s 2023 Fierce 50 list as a Patient Advocacy Honoree.